A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition:   Cholestasis, IntrahepaticInterventions:   Drug: GSK2330672;   Drug: Placebo;   Drug: Ursodeoxycholic acidSponsor:   GlaxoSmithKlineRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2013 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition:   Cholestasis, IntrahepaticInterventions:   Drug: GSK2330672;   Drug: Placebo;   Drug: Ursodeoxycholic acidSponsor:   GlaxoSmithKlineRecruiting - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2013 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition:   Cholestasis, IntrahepaticInterventions:   Drug: GSK2330672;   Drug: Placebo;   Drug: Ursodeoxycholic acidSponsor:   GlaxoSmithKlineRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2013 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition:   Cholestasis, IntrahepaticInterventions:   Drug: GSK2330672;   Drug: Placebo;   Drug: Ursodeoxycholic acidSponsor:   GlaxoSmithKlineRecruiting - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2013 Category: Research Source Type: clinical trials